Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
733
-
Total 13F shares, excl. options
-
69.7M
-
Shares change
-
+1.35M
-
Total reported value, excl. options
-
$22.8B
-
Value change
-
+$488M
-
Put/Call ratio
-
1.79
-
Number of buys
-
349
-
Number of sells
-
-330
-
Price
-
$327.56
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2024
838 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2024.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 733 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.7M shares
of 71.9M outstanding shares and own 96.81% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.99M shares), BlackRock, Inc. (7.45M shares), Bank of New York Mellon Corp (3.45M shares), STATE STREET CORP (3.25M shares), Artisan Partners Limited Partnership (3.11M shares), ALLIANCEBERNSTEIN L.P. (2.59M shares), BROWN ADVISORY INC (2.55M shares), FRANKLIN RESOURCES INC (1.78M shares), GEODE CAPITAL MANAGEMENT, LLC (1.78M shares), and APG Asset Management N.V. (1.44M shares).
This table shows the top 733 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.